A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

President Trump has vowed to impose tariffs on China, Mexico, and Canada. They could make common medicines less affordable.

Additionally, FPT’s digital transformation solution for Long Chau Pharmacy has enhanced the customer experience by enabling ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

UK-based global pharma company AstraZeneca and US consumer products company Honeywell have announced a partnership to build a new "next generation" inhaler with a propellant that reduces Global ...

President Trump rescinded an executive order that prompted the creation of three Medicare drug-pricing experiments ...

Chinese regulators are investigating the quality of domestic generic drugs after a rare public backlash against a cost-cutting campaign that prioritised their use in the national healthcare system but ...

Following this approval, AstraZeneca has the option ... Current albuterol rescue inhalers alleviate acute symptoms, but do not treat the underlying inflammation in asthma.” ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...